Competitive Intelligence

Expanding Into Asia-Pacific: Life sciences opportunities and strategies for success
Objective :

Assessment of leakiness of the client for the application of strategic counter-CI approaches

Problem Statement:

A large client based in Europe involved DelveInsight to assist in assessing counter-intelligence strategies for them, after evaluation of their level of leakiness among middle and high-level employees. The client was keen to instill a healthy knowledge of Competitive Intelligence approaches and processes amongst them.

Our Methodology:
  • Assessment of the leakiness of the client through counter CI efforts
  • Assessment of key competitors to benchmark own’s leakiness
  • Ranking of the client as per the low-medium-high level of leakiness framework of DelveInsight
Results:
  • DelveInsight showcases the processes through which the client could provide information for competitive intelligence building.
  • Provided overall leakiness scenario, and involved client’s Key Personnel in small seminar to appraise them of the CI domain


Related Insights

In-Licensing Opportunity
In-Licensing Opportunity

A large client based in USA, involved in drug delivery devices, with effective marketing and commercialization presence across the globe, wanted to in-license potential dMTS based drug delivery asset... [...]

View Case
Out Licensing Opportunity
Out-Licensing Opportunity

A small pharmaceutical client based at Sweden, Europe with capabilities around a neonatal mesenchymal cells involved DelveInsight to identify a licensing partner for their stem cells product, from acr... [...]

View Case
Go-To-Market Strategy
Go-To-Market Strategy

A medium pharmaceutical client based in United States with biosimilar commercial capabilities involved DelveInsight to identify commercial processes and strategies to launch their biosimilar in Europe... [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.